Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccinationElisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, Jens Klotsche, Fredrik Nils Albach, Alexander ten Hagen, Jan Zernicke, Elvin Ahmadov, Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Florian Kurth, Leif Erik Sander, Gerd R Burmester, Florian Klein, Robert Biesen
10 October 2022
Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritisDavid Stahl, Carola tho Pesch, Carolin Brück, Ruth L Esser, Jan Thiele, Veronica Di Cristanziano, David M Kofler
10 October 2022
Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunityCassandra Calabrese, Elizabeth Kirchner, Alexandra Villa-Forte, Rula A Hajj-Ali, Brandon P Moss, James P Fernandez, Leonard Calabrese
19 September 2022
Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohortMarie-Elise Truchetet, Elodie Drumez, Thomas Barnetche, Claire Martin, Mathilde Devaux, Tiphaine Goulenok, Alexandre Maria, Jean Schmidt, Nassim Ait Abdallah, Isabelle Melki, Eric Hachulla, Christophe Richez
16 September 2022
Impact of the COVID-19 pandemic on work productivity in patients with spondyloarthritis: results from the Dutch SpA-Net registryCasper Webers, Astrid van Tubergen, Harald E Vonkeman, Annelies Boonen
15 September 2022
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccinationIoana Andreica, Arturo Blazquez-Navarro, Jan Sokolar, Moritz Anft, Uta Kiltz, Stephanie Pfaender, Elena Vidal Blanco, Timm Westhoff, Nina Babel, Ulrik Stervbo, Xenofon Baraliakos
14 September 2022
Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine SurveyMichael DiIorio, Kevin Kennedy, Jean W Liew, Michael S Putman, Emily Sirotich, Sebastian E Sattui, Gary Foster, Carly Harrison, Maggie J Larché, Mitchell Levine, Tarin T Moni, Lehana Thabane, Suleman Bhana, Wendy Costello, Rebecca GraingerSee the full list of authors
14 September 2022
Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registrySu-Ann Yeoh, Milena Gianfrancesco, Saskia Lawson-Tovey, Kimme L Hyrich, Anja Strangfeld, Laure Gossec, Loreto Carmona, Elsa F Mateus, Martin Schäfer, Christophe Richez, Eric Hachulla, Marie Holmqvist, Carlo Alberto Scirè, Hanns-Martin Lorenz, Reinhard E VollSee the full list of authors
13 September 2022
COVID-19-associated arthritis: an emerging new entity?Bayram Farisogullari, Ana S Pinto, Pedro M Machado
13 September 2022
Reactive arthritis after SARS-CoV-2 infectionSophia Dombret, Alla Skapenko, Hendrik Schulze-Koops
12 September 2022
